Pulse Biosciences, Inc Common Stock (DE)
Follow $PLSE
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PLSE by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PLSE moving today?
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PLSE overview
Related filings and maps
Congress activity in PLSE
No receipt-qualified Congressional disclosure is present for PLSE in the cached public ledger.
PLSE contract awards, year to date.
Public federal awards linked to this ticker.
PLSE lobbying filings, year to date.
Registered lobbying filings matched to Pulse Biosciences, Inc Common Stock (DE).